Atlas Trials

Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy

Clinical trial NCT02412592 · UNKNOWN

Trial details

NCT number
NCT02412592
Sponsor
Beijing Ditan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Chronic Hepatitis B
Start date
2013-01-01
Primary completion
2018-12-01
Enrollment
260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.